About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: May 2016
The Drop in OPDP Enforcement
Back when the Office of Prescription Drug Promotion (OPDP) issued regulatory action letters on a regular basis (either Warning Letters or Untitled Letters) regarding what the agency saw as infractions in the course of promotional speech, I would post a … Continue reading
Posted in Warning Letters
Comments Off on The Drop in OPDP Enforcement
More Space on Twitter – Does it Change Things for Pharma?
This week media carried reports that Twitter was going to making a shift in policy regarding space. Until now, you have been limited to 140 characters in your tweeting which included space for your – albeit tiny – URL and/or … Continue reading
Posted in Social Media
Comments Off on More Space on Twitter – Does it Change Things for Pharma?
Which Way on the Public Health Narrative on Zika?
Back in February in a post entitled “From HIV to Zika – The Role of Communications“, I listed several of the hallmark characteristics involving the communications environment and emerging pathogens, drawing not only on recent observations with respect to Ebola, … Continue reading
Posted in Current Affairs
Tagged Public Health, Zika
Comments Off on Which Way on the Public Health Narrative on Zika?